News

Join me at Laboratory Automation 2021

I invite you to attend the 5th Annual Laboratory Automation Virtual Event, an online-only virtual event occurring on May 19, 2021.

The Laboratory Automation 2021 Virtual Conference will provide the opportunity to further the discussion of the advantages made regarding instrumentation and methodologies used to increase the efficiency and effectiveness of research in the lab. The Laboratory Automation committee has carefully planned and selected world-renowned keynote and featured speakers that will cover various research areas.

This year’s event includes the following topics:

• Microfluidic Technologies Enabling Automation
• High Throughput Biology
  • Antibody Discovery
• LIMS and Regulatory Compliance

I am excited to be among the group of academics and industry leaders presenting this year. I invite you to attend to learn more about LIMS management of the Clinical Sample Life Cycle in a Regulatory Environment. This presentation describes how the integration of a LIMS system can simplify your clinical sample workflows and ensure GLPC compliance.

Register today for free to discover the subtopics for each track and to get access to the exhibit hall and educational presentations delivered by academic and industry leaders. Following each presentation, participants have the ability to earn free continuing education credits. Don’t miss this networking opportunity that gives you the chance to share ideas and solutions with colleagues from all over the world.

Looking forward to seeing you there!

Sincerely,

Sue Keeler

Managing Director, Colibri Scientific

Introduction

Biology aside, opinion on vital factors for the success of a clinical trial depends on the ‘hat’ worn by the person asked.

When asked the most important considerations, the trial sponsor will have such aspects as patient safety, clinical endpoints, patient recruitment, compliance, cost and timings, high up on their priority list. These are, of course, all vitally important, however, rarely is sample quality considered at all or, at the very least, will be found low down the list. Asking a laboratory analyst the same question is likely to generate a much more sample-centric response, highlighting such things as consistent processing methodologies between sites, accurate sample labelling and documentation and good quality samples.

To read more and for access to the full Whitepaper, please click the below link:

Exploring risks affecting clinical sample quality

Having the words “positive” and “Covid-19” is something that we have all learned to dread over the last few months.

However, with this year proving to be challenging, in so many aspects, we need to remember and celebrate our successes during this time.

It is so easy to refer to colleagues as a Team but what does that actually mean? Perhaps, having the same line manager or performing the same job? A quick Google gives the definition of “A group of individuals who come together to achieve a common goal”. The issue this year is that no one has quite known what that goal is. We quickly had to adapt to working from home. We quickly had to modify processes to maintain compliance. We learned that when working on-site in bubbles, everything just takes that little bit longer. A new day, a new challenge.

Through all that, the Colibri team have worked tirelessly (not quite round the clock but, at times, getting very close) to ensure that they never missed a deadline and delivered the same quality standard that our clients have come to expect.

As Managing Director of Colibri, I am immensely proud of how the team has come together in their discrete locations to kick that ball straight into the top corner of the elusive goal.

Huge congratulations to everyone at Colibri in achieving difficult targets and let it be on record that in 2021, we party!

Merry Christmas and good health to all our clients and associates that we have had the pleasure of working with through 2020.

Strong business growth has necessitated increased headcount at Colibri Scientific and we are delighted to welcome Ashleigh Mattock to our team as Sample Manager.  Ashleigh has substantial experience from central laboratories, such as Covance and will oversee all aspects of the sample management process and governance.

Colibri Scientific is delighted to announce that Robert Moore has joined our board as a Non-Executive Director.

Robert is a highly experienced leader with a successful 30-year record of starting, growing and managing profitable privately owned businesses in the life-science sector and with significant experience in the corporate environment working for large public US multinationals.

Colibri’s Managing Director, Sue Keeler, said “Robert has worked closely with the Colibri Management team since the company’s inception and we are delighted that he has chosen to formally join the company and demonstrated his faith in our exciting and growing business.

Welcome to the team Robert!